Crossref
Evaluation of Disease Control in Patients with HAE-nC1INH Receiving Tranexamic Acid
Asthma Allergy Immunology · 23.12.2025 · 23 (3) · 328-334
DOI: 10.21911/aai.2025.1073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asthma Allergy Immunology, online erschienen am 23.12.2025. Verfasst von Gulseren TUNCAY und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
TUNCAY, G., SOYER, O. U., BIRBEN, E., DAMADOGLU, E., KARAKAYA, G., & KALYONCU, A. F. (2025). Evaluation of Disease Control in Patients with HAE-nC1INH Receiving Tranexamic Acid. Asthma Allergy Immunology, 23(3), 328-334. https://doi.org/10.21911/aai.2025.1073
Vancouver
TUNCAY G, SOYER OU, BIRBEN E, DAMADOGLU E, KARAKAYA G, KALYONCU AF. Evaluation of Disease Control in Patients with HAE-nC1INH Receiving Tranexamic Acid. Asthma Allergy Immunology. 2025;23(3):328-334. doi:10.21911/aai.2025.1073
BibTeX
@article{TUNCAY2025,
author = {TUNCAY, Gulseren and SOYER, Ozge UYSAL and BIRBEN, Esra and DAMADOGLU, Ebru and KARAKAYA, Gul and KALYONCU, A. Fuat},
title = {Evaluation of Disease Control in Patients with HAE-nC1INH Receiving Tranexamic Acid},
journal = {Asthma Allergy Immunology},
year = {2025},
volume = {23},
number = {3},
pages = {328--334},
doi = {10.21911/aai.2025.1073}
}
EUVIMED